M Nishizawa Selected Research

M Nishizawa Research Topics

Disease

2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 09/2000
2	Leukoencephalopathies 01/2017 - 01/2017
2	Multiple System Atrophy 05/2011 - 03/2008
2	Multiple Sclerosis 11/2009 - 08/2007
2	Neuromyelitis Optica (Devic's Disease) 11/2009 - 06/2009
2	Neoplasms (Cancer) 08/2000 - 03/2000
2	Hepatocellular Carcinoma (Hepatoma) 08/2000 - 03/2000
1	Peripheral Arterial Disease 09/2017
1	Chronic Limb-Threatening Ischemia 09/2017
1	Large Granular Lymphocytic Leukemia 12/2010
1	Demyelinating Diseases (Demyelinating Disease) 11/2009
1	Myelitis 11/2009
1	Optic Neuritis (Retrobulbar Neuritis) 11/2009
1	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 09/2009
1	Alzheimer Disease (Alzheimer's Disease) 09/2009
1	Sudden Death 10/2008
1	Sleep Apnea Syndromes (Sleep Apnea) 03/2008
1	Graves Disease (Basedow Disease) 12/2007
1	Autoimmune Diseases (Autoimmune Disease) 12/2007
1	Thymus Hyperplasia 12/2007
1	Vocal Cord Paralysis 02/2007
1	Myasthenia Gravis 02/2007
1	X-Linked Bulbo-Spinal Atrophy 08/2004
1	Spastic Ataxia 01/2004
1	Miyoshi myopathy 06/2003
1	Distal Myopathies (Distal Muscular Dystrophy) 06/2003
1	Metrorrhagia (Spotting) 12/2001
1	Aphthous Stomatitis (Aphthous Ulcer) 12/2001
1	Rheumatoid Arthritis 09/2001
1	Stomach Neoplasms (Stomach Cancer) 04/2001
1	Myoma 01/2001
1	Infections 12/2000
1	Ischemia 11/2000
1	Hypoxia (Hypoxemia) 11/2000
1	Hepatoblastoma 08/2000
1	Breast Neoplasms (Breast Cancer) 02/2000
1	Tuberous Sclerosis (Bourneville's Disease) 01/2000
1	Brain Edema (Cerebral Edema) 01/2000
1	Brain Ischemia (Cerebral Ischemia) 01/2000
1	Infarction (Infarctions) 01/2000

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 11/2009 - 11/2000
2	Macrophage Colony-Stimulating FactorIBA 01/2017 - 01/2017
2	Aquaporins (Water Channels)IBA 11/2009 - 01/2000
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2000 - 03/2000
1	Interleukin-6 (Interleukin 6)IBA 11/2009
1	AutoantibodiesIBA 11/2009
1	Immunoglobulin G (IgG)IBA 11/2009
1	InterleukinsIBA 11/2009
1	CytokinesIBA 11/2009
1	Amyloid (Amyloid Fibrils)IBA 09/2009
1	Flavin-Adenine Dinucleotide (FAD)IBA 09/2009
1	Aquaporin 4IBA 06/2009
1	AntibodiesIBA 06/2009
1	Cholinergic ReceptorsIBA 12/2007
1	anti-aquaporin 4 autoantibodyIBA 08/2007
1	myasthenia gravis anti-skeletal muscle antibody (ASMA)IBA 02/2007
1	Leuprolide (Lupron)FDA LinkGeneric 08/2004
1	Retinaldehyde (Retinal)IBA 01/2004
1	DysferlinIBA 06/2003
1	SuspensionsIBA 12/2001
1	Polystyrenes (Polystyrene)IBA 12/2001
1	irsogladineIBA 12/2001
1	GoldIBA 09/2001
1	Pepsinogen A (Pepsinogen)IBA 04/2001
1	Protein Isoforms (Isoforms)IBA 01/2001
1	Leukocidins (Leukocidin)IBA 12/2000
1	NF-KappaB Inhibitor alphaIBA 11/2000
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 11/2000
1	NF-kappa B (NF-kB)IBA 11/2000
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 11/2000
1	polyglutamineIBA 09/2000
1	Tryptophan (L-Tryptophan)FDA Link 02/2000
1	trans-sodium crocetinate (crocetin)IBA 01/2000
1	Messenger RNA (mRNA)IBA 01/2000
1	Ion Channels (Ion Channel)IBA 01/2000

Therapy/Procedure

2	Transplantation 12/2010 - 11/2000
2	Tracheostomy 10/2008 - 03/2008
1	Surgical Amputation (Amputations) 09/2017
1	Contraindications 05/2011
1	Continuous Positive Airway Pressure 10/2008
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 10/2008
1	Sutures (Suture) 01/2000